BAY-1125976

DB33584InvestigationalSmall molecule

BAY-1125976: Overview.

Mechanism: Pharmacologically active on RAC-alpha serine/threonine-protein kinase and RAC-beta serine/threonine-protein kinase
Curator reviewed
Formula / weight: C₂₃H₂₁N₅O · 383.455 g/mol (avg)
Code names: BAY-1125976

Resolves to

Compound

Structure

InChIKeyJBGYKRAZYDNCNV-UHFFFAOYSA-NSMILESNC(=O)C1=NN2C(C=C1)=NC(=C2C1=CC=CC=C1)C1=CC=C(C=C1)C1(N)CCC1

Targets

What you can answer from here — as of September 16, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with BAY-1125976, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.